Q1 Fiscal Year 2025
- Excellent equipment book-to-bill ratio of 1.21
- Comparable revenue growth of 5.7%
- Imaging comparable revenue growth of 7.6%; adjusted EBIT margin of 18.7% impacted by special items
- Diagnostics comparable revenue growth of 1.6%; adjusted EBIT margin of 7.8%
- Varian comparable revenue growth of 6.2%; adjusted EBIT margin of 17.1%
- Advanced Therapies comparable revenue growth of 5.1%; adjusted EBIT margin of 14.1%
- Overall adjusted EBIT margin of 15.0%, above prior-year quarter
- Free cash flow of around €810 million, more than tripled from prior-year quarter
- Adjusted basic earnings per share of €0.51, above prior-year quarter
Outlook for Fiscal Year 2025
We confirm our expectation of comparable revenue growth of between 5% to 6% compared with fiscal year 2024 and adjusted basic earnings per share of between €2.35 and €2.50.
Bernd Montag, CEO of Siemens Healthineers AG:
”We have made a strong start to the year. Our performance is consistently improving from a high base thanks to the efforts of the whole Healthineers team.”